Episode 509 New Alzheimer's Disease Treatment
Eisai Co., Ltd. and Biogen Inc. announced on January 6th that under the Accelerated Approval Pathway the U.S. Food and Drug Administration (FDA) has approved lecanemab-irmb, which has the brand name in the United States of LEQEMBITM, for the treatment of Alzheimer’s disease. The approval is based on Phase 2 data that demonstrated that LEQEMBI reduced the accumulation of Aβ plaque in the brain, a defining feature of Alzheimer’s disease. Newt’s guest is Dr. Marwan Sabbagh, MD. He is a behavioral neurologist in the Alzheimer’s and Memory Disorders Program and a professor in the Department of Neurology at Barrow Neurological Institute and was one of the leading doctors of the study.
https://www.gingrich360.com/2023/01/13/newts-world-episode-510-new-alzheimers-disease-treatment/
-
2:53
Reuters
11 months agoHow will this new drug change Alzheimer's treatment?
1.92K5 -
1:49
Just the News Articles
1 year agoData suggests Alzheimer's drug may benefit some patients
23 -
12:22
Peak Human Labs
1 year ago $0.02 earnedUpdates in Alzheimer's Prevention and Treatment
37 -
13:44
Peak Human Labs
1 year agoNew Breakthrough Alzheimer's Drug Approved!
32 -
1:16
Top Usa NEWS FEEDER
1 year agoFDA Approves New Drug for Early Treatment of Alzheimer’s
25 -
3:52
Last World News Channel
1 year agoNew drug can slow the development of Alzheimer's
-
2:42
Last World News Channel
1 year agoNew Alzheimer's drug is first 'to target the root cause'
2 -
9:09
PropheticEye
5 months agoNew Alzheimer's Drugs???
171 -
6:37
Last World News Channel
1 year agoNew Alzheimer's drug offers hope to patients and caregivers
4 -
13:43
TheRealTruthAboutHealth
1 year agoThe Three Phases Of Alzheimer's Treatment
61